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Genome assembly in its two decades of history has produced significant research, in terms of both biotechnology and computational
biology. This contribution delineates sequencing platforms and their characteristics, examines key steps involved in filtering and
processing raw data, explains assembly frameworks, and discusses quality statistics for the assessment of the assembled sequence.
Furthermore, the paper explores recent Ubuntu-based software environments oriented towards genome assembly as well as some
avenues for future research.
1. Introduction
Genome assembly involves taking smaller fragments, called
“reads,” and assembling them together to form a cohesive
unit, called the “sequence.” However, simply assembling all
the reads into one contiguous sequence, a “contig,” is not
enough. One has to ensure that the assembled sequence
does indeed resemble what is truly present in the cell. Some
common hurdles are low coverage areas, false positive read-
read alignments, false negative alignments, poor sequence
quality, polymorphism, and repeated regions of the genome.
An even more fundamental concern lies in the difficulty of
determining which of the two strands was finally reported in
the sequencing procedure.Moreover, as a number of research
domains draw suitable conclusions from the sequence itself,
a sequence that has not been reported accurately may poten-
tially affect subsequent analyses [1].
Sanger’s deoxydinucleotide sequencing with large and
accurate reads opened the door to whole-genome sequenc-
ing and deciphered the first human genome in 2001 [2,
3]. Sanger’s approach is still commercially available with
improved capillary electrophoresis, enhanced speed and
accuracy, and longer read lengths. NIH’s $1,000 genome
project led researchers to develop efficient, economical, and
high-throughput sequencing platforms introducing a new
paradigm called next-generation sequencing (NGS). For
instance, Roche’s 454 GS, Illumina’s MiSeq and HiSeq, ABI’s
SOLiD, and Life Technologies’ Ion Torrent and Proton Tor-
rent platforms all sequence the same genome at a fraction of
the time and cost of the first-generation sequencing methods
[4].
NGS platforms now produce terabytes of data thereby
challenging traditional software tools and hardware architec-
tures which were not designed to process such large amounts
of data. This triggered a need to develop algorithms and sta-
tistical tools with improved memory management and time
complexity in parallel to the development of NGS platforms.
This contribution is intended to act as an introductory
note to scientists and researchers working in the area of
genome assembly. Section 2 provides an overview of NGS
platforms. Section 3 discusses raw data, Sequencing Read
Archive, and FASTA and FASTQ file formats. It provides
particulars on filtering and correcting raw data. Additionally,
the second section enforces the need to report accurate
results. Section 4 supplies necessary answers addressing the
draft assembly process. Section 5 reviews common metrics
employed to evaluate the assembly and Section 6 highlights
recent software environments oriented towards NGS. Finally,
Section 7 projects considerations on possible future research
trends.
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2. Overview of Next-Generation
Sequencing Platforms
Among NGS platforms, Roche’s 454 sequencing is based
on Nyren’s pyrosequencing approach [5]. Roche’s approach,
referred to as “sequencing by synthesis” (SS), takes one
DNA strand as a template and then uses it to synthesize
the sequence of its complementary strand. Roche’s SS uses
four polymerase enzymes to extend several DNA strands in
parallel. Whenever a nucleotide attaches itself onto template
DNA, a pyrophosphate molecule is produced which emits
light when triggered [6]. The bioluminescence produced by
these bases helps in recognizing the bases and, therefore, the
sequence. Some characteristics of Roche sequencing include
its automated procedures and high speed, while some draw-
backs are lower read accuracy for homopolymer segments of
identical bases and relatively high operating costs [7].
Illumina, another NGS company, differs from Sanger in
several features. Sanger’s approach uses dideoxynucleotide
for irreversible termination of primer extension, whereas
Illumina employs reversible terminators for primer extension
of the complementary strand. Illumina’s 3-O-azidomethyl
reversible terminators are tagged with four different colored
fluorophores to distinguish between the four nucleotides.
Therefore, using these reversible terminators aids in observ-
ing the identity of the nucleotides as they attach onto theDNA
fragment because the fluorophores are detected by highly
sensitive CCD cameras [8]. Illumina’s method significantly
reduces the duration of sequencing and assumes a $1000 price
tag for 30× human genome. Illumina’s sequencing scheme
shows some benefits over Roche’s pyrosequencing; however,
its characteristic short read lengths (<300 bp) present chal-
lenges when resolving short sequence repeats.
In addition to Roche and Illumina, Applied Biosystems’
SOLiD sequencer is another key player among genome
sequencers. SOLiD uses the principle of “sequencing by
ligation” (SL). SL differs from Illumina in its method for lig-
ation of octamer oligonucleotides. SL uses dibase fluorescent
labeled octaoligonucleotide adaptors which link the template
DNA and are bound with 1 𝜇m magnetic beads [9]. At each
step, SOLiD’s technique encrypts two bases simultaneously
and every nucleotide is cross-examined twice: first as the right
nucleotide of a pair and then as the left one. This approach
reduces homopolymeric sequencing errors. However, similar
to Illumina, SOLiD generates short read length data which
incur complications in the sequence assembly.
Collectively, these high-throughput sequencers have
substantially reduced the cost (≤$0.1/Mb) and duration
of genome sequencing. However, additional technologies
with enhanced performance have been proposed recently.
The advent of nonoptic, semiconductor-based genome
sequencers has shown potential. Manufacturers like Life
Technologies developed Ion Proton and Ion PGM, both
of which use SS amplification and hydrogen ion sensing
semiconductors [10]. The sequence is obtained by sensing
hydrogen ions emitted when nucleotides incorporate them-
selves onto template DNA, a process catalyzed by DNA poly-
merase.Massively parallel transistor-based integrated circuits
with about two million wells allow simultaneous detection
of multiple reactions. Furthermore, signal processing tools
translate voltage fluctuations into base calls for successive
nucleotides [10].
Another technique which has been recently proposed is
the single-molecule real-time (SMRT) sequencing, introduced
by HeliScope [11]. SMRT sequencing scheme is free of library
preparation or amplification errors. PacBioRS II (byHeliScope)
utilizes SMRT sequencing and can produce about 50,000
reads ranging from 15,000 to 40,000 bases in length in just
three hours. The extended read length facilitates sequence
alignment and improves precision in drafting an assembly,
simply because long repetitive DNA fragments can be easily
spanned. Interestingly, Roche will be phasing out its in-
house 454 sequencers in 2016 in favor of PacBio’s SMRT
sequencers. Roche plans to maintain its participation in NGS
market, not by developing its own sequencers, but rather by
becoming an exclusive seller for in vitro diagnostic products
based onPacBio’s SMRT sequencing platform (http://www.bio-
itworld.com/BioIT Article.aspx?id=131053, accessed on Dec.
12, 2015). Together with nonoptic semiconductor nanopore
technology, SMRT sequencers are referred to as “third-genera-
tion-sequencers” [12–14].Overall, the above-mentioned high-
throughput sequencers have substantially reduced the dura-
tion and cost of sequencing ($0.1/Mb).
Companies are investing significant resources to upgrade
existing technologies and introduce newer machines. It is
hoped that many third-generation-sequencers are expected
to surface, coupling SMRT sequencing with principles of
electrothermodynamics, quantum physics, and nanopore
technology [13–15]. Existing platforms are currently designed
to cater for de novo synthesis, wholegenome/whole-exome
and transcriptome synthesis, targeted resequencing, RNA
profile ChIP-Seq, mutation detection, and metagenomics.
Platforms are usually accompanied by bioinformatics tools.
Tables 1, 2, and 3 present some important details about
current sequencers.
3. Preliminary Data Processing Steps
Software tools and applications enter the research process
once the sequencers fulfill their role of generating reads. The
aim of this and the next set of sections is to provide an
outline of the individual steps involved in transforming raw
data into the novel genome, as presented in Figure 1. The set
of interconnected methods are referred to as a “pipeline.”
The process starts by using the data generated by one’s
lab or by downloading the data from the Sequencing Read
Archive (SRA) [16]. Data is present in “.SRA” format and
must be converted into .FASTQ file format by employing
the SRA toolkit (http://www.ncbi.nlm.nih.gov/Traces/sra/).
Once converted, the FASTQ format adopts a four-line repre-
sentation to display the sequence and its associated quality [1]:
@ Sequence Identifier
Sequence line(s)
+ Sequence Identifier
ASCII encoding of quality values
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Table 2: The table enlists the strong points and challenges pertaining to some of the sequencing platforms.
Platform Positive points Challenges
Sanger (Applied Biosystems 3730xl) Long read length; good for individualgene analysis
Slow; expensive; poor quality due to
primer dimer
454 GS+ Long read length; fast; low cost for smallstudies
High error rate for homopolymer read;
low throughput; will be phased out in
2016
454 GS FLX+ Long read length
High error rate homopolymer read; low
throughput; large capital cost; will be
phased out in 2016
MiSeq High throughput; ideal for small genomeproject Short read length
HiSeq X Ten High throughput; ideal forwhole-genome project Short read length
NextSeq 500 High throughput; ideal for small to largescale project Short read length
SOLiD 5500xl High throughput Short read length; poor output datadistribution and arduous data analysis
Ion Proton I Ideal for small project; shorter run time;leading future technology Higher error rate; larger cost per Mb
Ion PGM 318 Low capital investment and running cost;shorter run time Higher error rate; larger cost per Mb
Polonator G.007 Cost-effective; open resource Obsolete
Helicos HeliScope Single-molecule sequencing; simplesample preparation and data analysis Short read length; obsolete
PacBio RS II Single-molecule real-time sequencing;longest available read length High error rate
Table 3: Recent sequencing platforms: these platforms are relatively new and to date (Nov. 15, 2014) there is not enough information to
incorporate them into Table 1.
Platform Company Biotechnology Resource
GENIUS GenapSys Proton sensing by pH and temperature change http://genapsys.com/
NanoTag sequencer Genia Electric current change produced by nanotag releasedfrom incorporation of nucleotide http://geniachip.com/
GnuBIO platform GnuBIOsystem Oligo hexamers hybridization in microfluidics http://gnubio.com/
∗ Lasergene 3󸀠-OH unblocked reversible terminator http://lasergen.com/
∗ Nabsys Hexamer oligonucleotides hybridization mappingthrough nanopore arrays http://nabsys.com/
MinION and GridION
Oxford
Nanopore
Technologies
Strand DNA or exonuclease cleaved nucleotides pass
through nanopores change electric current flow rate https://nanoporetech.com/
∗
Strato
Genomics
Technology
Conversion of DNA into Xpandomer http://stratosgenomics.com/
∗Lasergene, Nabsys, and Strato Genomics are working on newer platforms.
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Figure 1: Flow chart for DNA assembly pipeline. Some commonly used tools are mentioned next to each step [36]. Please refer to [19, 35, 37–
88] for details on the above-mentioned tools.
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ASCII characters utilized in the last line of the above-
mentioned SRA format symbolize quality values (𝑄-values).
𝑄-values are log-probabilities illustrating the quality of each
base call. For example, for Sanger the formula is
𝑄PHRED = −10 × log10 (𝑃𝑒) , (1)
where 𝑃
𝑒
is the probability of determining a base incorrectly
[17, 18]. For ASCII encoded quality values the following
characters depict an increasing order of quality:
!"#$%&󸀠() ∗ +, −./0123456789:; <=>?@ABCDEFG
HIJKLMNOPQRSTUVWXYZ[\∧‘abcdefghijklmno
pqrstuvwxyz{|} ∼
Similar to FASTQ, FASTA format seems like an abridged
version of FASTQfile format. It maintains a two-line arrange-
ment to display the sequence and contains no mention of its
quality:
@ Sequence Identifier
sequence line(s)
Once reads are received in their correct format, one must
trim adapter sequences, filter, or trim low quality ends and
collapse identical reads. A naive approach is to remove all
reads that contain the flag “𝑁.” An improved method retains
all reads that have an overall quality 𝑃qual > 𝑞, where 𝑞 is a
user-defined parameter [19–23]. A more enhanced approach
consists in matching reads against known ribosomal and
heterochromatin DNA and removing them should they
match [24]. Nevertheless, since a significant portion of raw
data contains errors one must correct them.
4. Assembly Process
The primary aim of the assembly process is to connect all
reads together, one after another, to form a single contiguous
sequence. Interestingly, due to the inherent nature of the
problem, graph theory, especially de Bruijn graph, models
very well such a process [25]. In graphical models indi-
vidual nodes symbolize reads whereas edges between the
nodes emphasize “overlaps” between reads. Once the overlap
between all reads is established, the task at hand is to generate
a “layout” by searching for a single path from beginning,
that is, the root of the graph structure, to the end, the leaf
of the graph structure, as illustrated in Figures 2 and 3. As
such, generating a layout is very challenging, because not one
but multiple disjointed graphs are realized, each depicting a
contig. In addition, each graph has many loops portraying
repeat regions as well as multiple branches, both long and
short. All these hazards need to be resolved. Branches that
are small may be discarded, while longer branches compete
with one another to serve as potential representatives for each
contig. Loops portray repeat regions, so onemust decide how
many times the repeats should be placed within the final
assembly. Nevertheless, assemblers do spend a significant
amount of time resolving potential hazards, in multiple ways.
The output is a collection of contigs that need to be ordered,
appended, and elongated, a process called “scaffolding” [25–
28].
Overlap
Consensus
sequence
Layout
Figure 2:De novo assembly: reads that overlap each other are shown
to align at appropriate places with respect to one another, thereby
generating the layout. The layout, in turn, constructs a consensus
sequence, simply by basing itself on the majority base call. The
above-mentioned framework is called “Overlap-Layout-Consensus.”
Alignment
Reference
sequence
Consensus
sequence
Layout
Figure 3: Reference assisted assembly: reads align relative to a refer-
ence sequence setting up the layout.The layout, in turn, constructs a
consensus sequence, simply by basing itself on the majority base call.
Please note that the reads do not need to match perfectly with the
reference. The example shows a shaded region where the consensus
sequence differs from the reference. This working scheme is called
“Alignment-Layout-Consensus.”
5. Evaluating the Quality of an Assembly
Evaluating the quality of an assembly requires analyzingmul-
tiple metrics. These statistics measure an assembly from
various standpoints. Table 4 illustrates some commonly used
assemblymetrics/statistics and their explanations. After eval-
uating the assembly it is recommended to visualize the assem-
bly in order to obtain a pictorial view of the draft. Figure 1
presents common tools used in each part of the pipeline.
6. Linux Based Distributions
The software environments pertaining to genome assembly are
many and as such need to be constantly maintained, config-
ured, andupdated. This repeated and continuous configuration
consumes a good amount of time and resources.Therefore, to
address these challenges, engineers and computer scientists
BioMed Research International 7
Table 4: Some common assembly statistics. Here an ↑ indicates higher is better while a ↓ implies less is better.
↑ / ↓ Description
↑
N50: quantified the length of the scaffold at which 50% of the total assembled size of the sequence is covered. NG50:
evaluated in a way similar to N50. However, here the length of the sequence is either known or predicted [1, 29]. NA50 and
NGA50: these metrics deal with aligned blocks rather than contigs [35]. Continuity: similar to N50, NA50, NG50, and
NGA50 there are other metrics like N75, NA75, NG75, NGA75, N90, NA90, NG90, and NGA90. Number of Genes: an
assembly which exhibits more highly conserved core Eukaryotic genes is considered better [29]. Accuracy: if an assembly
reports at least 90% of its bases with a minimum of 5× coverage, it is considered accurate. Choppiness: the average contig
length should be greater than a certain threshold. Otherwise, the assembly needs to be redrafted. Validity: the fraction of
assembly that can be confirmed by a reference sequence [29]. Completeness: an assembly is considered complete if the
scaffolds cover more than 90% of the actual genome. Length of the Longest Scaffold: typically the greater the length, the better
the assembly. Similar is the case of the shortest scaffold. Number of scaffolds > X, where X is a user-defined length. Similarly,
% age of scaffolds > X. Total Length of the Scaffolds and Total Scaffold Length as Percentage of Estimated Genome Size: the
closer it is to 100%, the better it is. Percentage of Contigs Scaffolded: percentage of contigs that were connected with one
another during the scaffolding process [1].
↓
Number of Gaps in the Assembly: by aligning paired-read data onto scaffolds one may determine scaffolding errors [1].
Number of Scaffolds: an assembly which has a smaller number of scaffolds would be assumed to be better. For example, the
optimum assembly would be one continuous sequence depicting the true sequence. LG50 Scaffold Count: number of
scaffolds counted in reaching NG50 threshold. Similar would be the case of LG75 and LG90. Percentage of Unscaffolded
Contigs: since contigs may remain unscaffolded.
Table 5: Comparison of different Linux distributions. Here LTS stands for Long Term Support and GUI refers to Graphical User Interface.
Operating system Free Base OS Software Open source LTS GUI ×86/×64 Cloud Script files
Baari ✓ Ubuntu 13.10 60+ genomeassembly tools ✓ ✓ Unity ×64 × ✓
Lxtoo ✓ Gentoo Linux 11
Sequence analysis,
protein-protein
interactions
✓ ✓ X11 Desktop ×86/×64 × ×
Open Discovery 3 × Fedora Sulphur 9
Molecular
dynamics, docking,
sequence analysis
× ✓ GNOME 2.22 ×86/×64 ✓ ×
BioBrew ✓ Red Hat 7.3 Appropriate forclusters ✓ × KDE, GNOME ×86 × ×
PhyLIS ✓ Ubuntu 8 Phylogenetics ✓ × Unity ×86/×64 × ×
DNALinux ✓ Xubuntu DNA and proteinanalysis ✓ × XFCE 4.2.2 ×86 ✓ ×
Bioconductor Buntu ✓ Ubuntu 12.04 BioconductorBuntu 2.11 ✓ ✓ Unity ×86/×64 × ×
BioLinux 7 ✓ Ubuntu 12.04
500+
bioinformatics
applications with 7
assembly tools
✓ ✓ Unity ×64 ✓ ×
have proposed multiple solutions built on Linux systems that
include within them all the necessary software needed by the
research group. Table 5mentions a few. As for genome assem-
bly, both Baari, an Ubuntu-derived operating system (http://
people.tamu.edu/∼bilalwajidabbas/Baari.html), and Geno-
buntu, a software package, provide about 60+ genome assem-
bly tools (https://sourceforge.net/projects/genobuntu/). It is
hoped the current set of tools will be constantly updated to
suit the ever growing needs of the scientific community.
7. Considerations and Concerns
Genome Online Database (GOLD) reports that as of Dec
12, 2015, 1,136 Archaeal, 49,983 Bacterial, 4,473 Viruses,
and 11,122 Eukaryotic genomes have been sequenced. There
remains plenty of room for work. The $1000 genome project
has reduced the cost significantly, but if personalized medi-
cation is expected to be effective and available to everyone,
the cost and time duration for sequencing need to be reduced
further. Processing raw data needs to be done both cheaply
and at ultra-fast rates. Spending about 50 hours of processing
time on a system with 20 microprocessor cores and 20 GB
RAM is not uncommon (as of 2014) [29]. Imagine trying
to sequence the genomes of an entire country’s population.
Transferring all the raw data via an Internet connection
from one country to another is not feasible. Therefore,
countries will have to provide for their own supercomputers,
and algorithms will need to be parallelized with careful
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attention to Hadoop and MapReduce frameworks [30–34].
Hadoop and MapReduce are ideal as both are designed to
process “big-data” using parallel and distributed algorithms
on clusters of systems [30–34].With somany obstacles ahead,
genome assembly will remain challenging for many years to
come.
Key Points
(i) NIH’s $1,000 genome project led researchers to
develop efficient, economical, and high-throughput
sequencing platforms. Examples include Roche’s 454
GS, Illumina’s MiSeq and HiSeq, ABI’s SOLiD, and
Life Technologies’ Ion Torrent and Proton Tor-
rent platforms. A brief comparison of these next-
generation sequencing platforms is presented.
(ii) Data provided by these platforms is transformed
into a sequence via a series of processes collectively
called a “pipeline.” It starts with trimming adapter
sequences, filtering low quality ends, and collapsing
identical reads. The final set of reads are then con-
nected together, one after another, to form contiguous
sequences, called “contigs.” The collection of contigs
needs to be ordered, appended, and elongated via a
process called “scaffolding.”
(iii) A number of software environments providing bioin-
formatics solutions have been provided over the years.
A brief comparison of some of these is presented here.
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